Stonepine Capital Management, LLC Verastem, Inc. Transaction History

Stonepine Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$1.25 - $3.14 $625,000 - $1.57 Million	-500,000 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$2.79 - $4.09 $1.4 Million - $2.05 Million	500,000 New	500,000 $1.48 Million
Q1 2018 May 14, 2018	SELL	$2.92 - $3.81 $657,000 - $857,250	-225,000 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$2.99 - $4.85 $672,750 - $1.09 Million	225,000	225,000 $691,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.19B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Stonepine Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Stonepine Capital Management, LLC with notifications on news.